SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical offers to buy balance stake in Taro

19 Oct 2011 Evaluate

Sun Pharmaceutical Industries, India's top drugmaker offered to buy all of the outstanding shares it does not already own in its Israeli unit Taro Pharmaceutical Industries. The drug maker proposed to buy per share at a consideration of $24.50 in cash representing a 25.96% premium over the most recent price of Taro common stock.

Further, this offer is subject to the approval of Taro board and such other authorities as may be required and subject to completion of necessary formalities as may be required.

Sun Pharmaceutical Industries manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1874.00 26.70 (1.45%)
11-May-2026 13:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1874.00
Dr. Reddys Lab 1295.00
Cipla 1321.95
Zydus Lifesciences 946.80
Lupin 2271.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×